REBECCA ANDERSON: Open Payments
NPI 1720054182 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 22 payments from 9 companies in 2025. Trend: 2023 $1,048 · 2024 $15 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $99 |
| ABBVIE INC. | 4 | $80 |
| Amgen Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 2 | $30 |
| Exact Sciences Corporation | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: UBRELVY, OTEZLA, Wegovy, Ozempic, MOUNJARO, Rybelsus, PREVNAR 20, Symbravo.
Industry payments across KS — which companies pay providers there.
